Alfred Spada
Plus aucun poste en cours
Fortune : 797 $ au 31/03/2024
Profil
Alfred P.
Spada is the founder of Conatus Pharmaceuticals, Inc. founded in 2005, where he held the title of Chief Scientific Officer and EVP-R&D from 2015 to 2020.
He also held former positions as President & CEO at Aya Biosciences, Inc., Department Director at Aventis Pharmaceuticals, Inc. and Rhone Poulenc AG, Inc., VP-Pharmaceutical & Preclinical Development at Idun Pharmaceuticals, Inc. from 2000 to 2005, and Principal at Rorer Pharmaceuticals, Inc. in 1990.
In addition, he will hold the position of Chief Scientific Officer & Executive VP at Histogen, Inc. in 2023.
Dr. Spada received a doctorate degree from Massachusetts Institute of Technology in 1984 and an undergraduate degree from Worcester Polytechnic Institute.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
HISTOGEN INC.
0,05% | 23/02/2023 | 2 214 ( 0,05% ) | 797 $ | 31/03/2024 |
Anciens postes connus de Alfred Spada
| Sociétés | Poste | Fin |
|---|---|---|
| HISTOGEN INC. | Chief Tech/Sci/R&D Officer | 30/09/2023 |
| HISTOGEN INC. | Founder | 01/05/2020 |
Idun Pharmaceuticals, Inc.
 Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2005 |
| Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01/01/1990 |
Aya Biosciences, Inc.
 Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Chief Executive Officer | - |
Formation de Alfred Spada
| Massachusetts Institute of Technology | Doctorate Degree |
| Worcester Polytechnic Institute | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| HISTOGEN INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Idun Pharmaceuticals, Inc.
Idun Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Idun Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the discovery and development of human therapeutics to control apoptosis. The company was founded by John C. Reed, Robert H. Horvitz, and Lawrence C. Fritz in March 1993 and is headquartered in San Diego, CA. | Health Technology |
Conatus Pharmaceuticals, Inc.
 Conatus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Conatus Pharmaceuticals, Inc. is a biotechnology company that focuses on the development and commercialization of novel medicines to treat chronic diseases. The firm engages in developing emricasan, an orally active pan-caspase inhibitor, for the treatment of patients with chronic liver disease and is designed to reduce the activities of human caspases. It also develops CTS-2090, an orally active selective caspase inhibitor, for diseases involving inflammasome pathways. The company was founded by Alfred P. Spada, Jennifer Giottonini Cayer, and Steven J. Mento on July 13, 2005 and is headquartered in San Diego, CA. | Health Technology |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
| Rhone Poulenc AG, Inc. | Process Industries |
| Rorer Pharmaceuticals, Inc. | |
Aya Biosciences, Inc.
Aya Biosciences, Inc. BiotechnologyHealth Technology Aya Biosciences, Inc. is a neuroscience company that is dedicated to improving the mental health and well-being of patients with neuropsychiatric diseases. The company is based in La Jolla, CA. The company is creating a pipeline of novel, orally active serotonin receptor agonists as a new class of therapeutics. The CEO of the company is Micah Anderson. | Health Technology |
